Company and Stock Identity

How GE HealthCare Connects to the Public Market

Company structure
Public company
Market access
Direct listing: Nasdaq: GEHC.
Stock name
GE HealthCare Technologies Inc.
Ticker and exchange
Nasdaq: GEHC
Research focus
Separate the value of AI software from the much larger imaging, ultrasound, patient-care, and pharmaceutical diagnostics businesses, then verify the authorization and evidence behind each product.

GE HealthCare became a separately traded public company in 2023 after its spin-off from General Electric.

Dated Market Snapshot

Sep 28, 2026 7:48 PM ET

Last price
$66.22
Change
-0.84%
Previous close
$66.63
52-week high / low
$89.77/$58.75
Market cap
30,163,607,909

Automated from Nasdaq. Check the exchange or investor-relations page for the current price.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... GE HealthCare Investor Relations ... Investor relations

GE HealthCare sets out its AI and digital portfolio for HIMSS 2026

The company presented AI and digital products across its enterprise healthcare portfolio at HIMSS 2026.

Why it matters: GE HealthCare is broad public-market exposure rather than a pure healthcare AI company. Research has to separate AI-linked products and revenue from the rest of the business.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Imaging science, software, AI, clinical applications, service engineering, regulatory affairs, product, sales, and hospital implementation.

Qualification signal: Role requirements vary from engineering degrees to clinical credentials and field-service training. Match the business unit and product before choosing a course or certification.

Check current roles at GE HealthCare. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
Primary use case
Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
Typical deployment
Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow

Evidence questions

  • Was the tool tested prospectively and independently on comparable equipment and patients?
  • What are sensitivity, specificity, false positive workload, and time-to-action effects?
  • How does performance vary by site, scanner, demographic subgroup, and disease prevalence?

Regulatory and workflow questions

  • Which FDA authorization covers the exact product version, modality, and intended use?
  • Who retains final clinical responsibility and how is disagreement with the AI handled?
  • What post-deployment monitoring and material update notification does the vendor provide?

Data and contract questions

  • Where are images and derived data processed and retained?
  • Which PACS, RIS, pathology, and EHR integrations are supported in production?
  • Can data be used for model improvement, and what controls govern secondary use?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources